These data suggest that mTOR signaling is involved in regulation of the balance of proliferation and differentiation of CSCs in Ras-dependent tumorigenesis and that transient inhibition of mTOR promotes tumor re-emergence via an increased CD133+ subpopulation. This evidence concerns the gene PROM1 and neoplasm.